Caspases: the proteases of the apoptotic pathway
- PMID: 9916986
- DOI: 10.1038/sj.onc.1202581
Caspases: the proteases of the apoptotic pathway
Abstract
Apoptosis, a morphologically defined form of physiological cell death, is implemented by a death machinery whose executionary arm is a family of cysteine proteases called caspases. These death proteases are part of a proteolytic caspase cascade that is activated by diverse apoptotic stimuli from outside and inside of the cell. The cell death machinery is evolutionarily conserved and composed of caspases and their regulatory components that include activators and repressors. These key components of the death machinery are linked to signaling pathways that are activated by either ligation of death receptors expressed at the cell surface or intracellular death signals. Caspases are normally present in the cell as proenzymes that require limited proteolysis for activation of enzymatic activity. Recent studies suggest that the basic mechanism of caspase activation is conserved in evolution. Binding of initiator caspase precursors to activator molecules appears to promote procaspase oligomerization and autoactivation. Enzymatic activation of initiator caspases leads to proteolytic activation of downstream (effector) caspases and cleavage of a number of vital proteins, resulting in the orderly demise and removal of the cell.
Similar articles
-
Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts.Oncogene. 1999 Mar 11;18(10):1781-7. doi: 10.1038/sj.onc.1202490. Oncogene. 1999. PMID: 10086332
-
Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes.Hepatology. 2001 Sep;34(3):548-56. doi: 10.1053/jhep.2001.27447. Hepatology. 2001. PMID: 11526541
-
Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.Cancer Res. 1999 Jul 1;59(13):3077-83. Cancer Res. 1999. PMID: 10397248
-
Caspases and cancer: mechanisms of inactivation and new treatment modalities.Exp Oncol. 2004 Jun;26(2):82-97. Exp Oncol. 2004. PMID: 15273659 Review.
-
Caspase-8 in apoptosis: the beginning of "the end"?IUBMB Life. 2000 Aug;50(2):85-90. doi: 10.1080/713803693. IUBMB Life. 2000. PMID: 11185963 Review.
Cited by
-
Lack of caspase-3 attenuates immobilization-induced muscle atrophy and loss of tension generation along with mitigation of apoptosis and inflammation.Muscle Nerve. 2013 May;47(5):711-21. doi: 10.1002/mus.23642. Epub 2013 Feb 9. Muscle Nerve. 2013. PMID: 23401051 Free PMC article.
-
The Curcumin Analogue 1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one Induces Apoptosis and Downregulates E6 and E7 Oncogene Expression in HPV16 and HPV18-Infected Cervical Cancer Cells.Molecules. 2015 Jun 29;20(7):11830-60. doi: 10.3390/molecules200711830. Molecules. 2015. PMID: 26132907 Free PMC article.
-
Transcriptional up-regulation and activation of initiating caspases in experimental glaucoma.Am J Pathol. 2005 Sep;167(3):673-81. doi: 10.1016/S0002-9440(10)62042-1. Am J Pathol. 2005. PMID: 16127148 Free PMC article.
-
Mitochondria: a hub of redox activities and cellular distress control.Mol Cell Biochem. 2007 Nov;305(1-2):235-53. doi: 10.1007/s11010-007-9520-8. Epub 2007 Jun 12. Mol Cell Biochem. 2007. PMID: 17562131 Review.
-
Caspase-mediated apoptosis in chicken postovulatory follicle regression.Vet Res Commun. 2008 Jan;32(1):13-9. doi: 10.1007/s11259-007-9005-y. Epub 2007 Jun 13. Vet Res Commun. 2008. PMID: 17564810
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources